Fundacao Para o Remédio Popular

What Fundacao Para o Remédio Popular does

Fundação Para o Remédio Popular (FURP), formerly Fundação Para o Remédio Popular "Chopin Tavares de Lima," is a state-owned pharmaceutical foundation established in 1968 and headquartered in Guarulhos, Brazil. Operating under the Government of the State of São Paulo, it functions as the state's official pharmaceutical laboratory, manufacturing, storing, marketing, distributing, and dispensing basic, strategic, and specialized medicines. FURP's primary mission is to ensure access to affordable essential medicines for the population of São Paulo state, directly addressing the high cost of pharmaceutical products faced by low-income citizens.

FURP's operational core is split across two main delivery channels: the Farmácia Dose Certa pharmacy network, which dispenses subsidized or free medications directly to citizens through physical storefronts across São Paulo state, and the Fornecimento de Medicamentos bulk supply service, which distributes generic medications to government health facilities and pharmacy networks. Supporting services include a pharmacovigilance program for drug safety monitoring, official certification issuance, monthly availability listings, and a contract-based sales program (Medicamentos à Venda por Contrato) for government procurement. The organization maintains a digital infrastructure of medication leaflets (Bulas) and operates a transparency portal and Ouvidoria (citizen feedback) system in compliance with state accountability requirements.

As a government foundation funded through state budget allocations, FURP does not operate as a commercial enterprise. Its revenue model relies on government appropriations rather than market-priced sales, and its pricing is structurally subsidized. The organization employs between 251 and 500 people and serves a single-customer geographic market (São Paulo state, Brazil). No revenue figures, funding rounds, M&A activity, or private equity involvement are disclosed in the available source material.

Name

Fundacao Para o Remédio Popular

Legal name

Fundação Para o Remédio Popular

Website

https://furp.sp.gov.br

Company type

Private

Founded year

1968

Operating status

Operating

Headcount range

501–1,000 employees

Short description

FURP is a São Paulo state government pharmaceutical foundation, established in 1968, that manufactures and distributes essential generic medicines to citizens through the Farmácia Dose Certa pharmacy network and direct supply to public health facilities.

Ownership category

akta.pro rank

Headquarters

HQ city

Guarulhos

HQ country

Brazil

HQ region

Latin America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure

Distribution channels3 records

Marketing channels3 records

Core offering

FURP is a state pharmaceutical laboratory that manufactures, stores, markets, distributes, and dispenses basic, strategic, and specialized generic medicines. It operates the Farmácia Dose Certa public pharmacy network throughout São Paulo state and supplies bulk medications to government health facilities and contracted entities.

Product overview

FURP (Fundação Para o Remédio Popular "Chopin Tavares de Lima") is a state pharmaceutical laboratory operated by the Government of São Paulo, Brazil. The organization operates as a single unified offering rather than a modular platform—producing and distributing generic medications primarily to serve the public healthcare system. The core products consist of the Farmácia Dose Certa pharmacy network (providing medications directly to citizens) and the Fornecimento de Medicamentos supply service (distributing to government health facilities). Supporting services include medication information leaflets (Bulas), pharmacovigilance monitoring, official certifications, and monthly availability listings. The product portfolio centers on pharmaceutical manufacturing and distribution rather than software technology products.

Differentiator

Problem solved

Functional benefit

Products and services

• Nossos Produtos (Our Products) The portfolio of generic pharmaceutical products manufactured by FURP, including prescription medications, OTC products, and health supplies produced by the state pharmaceutical laboratory. Intended for the population of São Paulo state and government health facilities.
• Farmácia Dose Certa A network of pharmacies operated by FURP that provides medications to the population of São Paulo state at reduced costs or free of charge. Targets low-income citizens needing affordable essential medicines.
• Fornecimento de Medicamentos (Medicine Supply) Bulk supply and distribution service of generic medications to government health facilities and pharmacy networks throughout São Paulo state. Intended for public healthcare system operators.
• Medicamentos à Venda por Contrato (Contract Medicine Sales) Contract-based medication sales service for entities purchasing FURP-manufactured medicines through government procurement contracts. Targets contracted institutional buyers.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Broad incumbents

• EMS: Brazil's largest domestic generic pharmaceutical manufacturer. Competes in the same generic-medicine procurement contexts as FURP and is a major supplier to the SUS, but operates commercially with no geographic cap and a far broader product portfolio.
• Eurofarma: Major Brazilian pharmaceutical company with broad branded generic, OTC, and hospital product portfolio. Significant direct competitor to FURP's generic-medicine portfolio in public-system bidding while also serving private retail and export channels.
• Cristália: Brazilian pharmaceutical company producing generics, hospital medicines, and anesthetics, with substantial public-sector presence. Similar generic-portfolio overlap with FURP and competing in the same SUS procurement contexts.
• Aché Laboratórios: Brazilian pharmaceutical company producing generic and branded medicines that competes in public-bidding contexts alongside FURP. Offers broader portfolio (prescription, OTC, generics) and operates with private-sector commercial flexibility.
• Biolab: Brazilian pharmaceutical company producing prescription and OTC medicines, including generics. Active participant in public-sector pharmaceutical bidding alongside FURP with a broader commercial portfolio and scale.

Direct peers

• LAFEPE: Pernambuco state pharmaceutical laboratory producing generics and public-health medicines. Comparable state-level pharmaceutical manufacturer with similar generic-product mix and public-mandate structure.
• Fundação Ezequiel Dias (FUNED): Minas Gerais state pharmaceutical foundation producing generic medicines, vaccines, and diagnostic reagents for the public system. Direct functional peer to FURP as another state-level government pharma foundation operating in a different Brazilian state.
• Instituto Butantan: São Paulo state-owned biomedical institute producing vaccines, serums, and biopharmaceuticals for the public health system. Co-located within São Paulo state and structurally similar to FURP as a state-government pharmaceutical producer serving SUS demand.
• Farmanguinhos (Fiocruz): Federal government pharmaceutical laboratory operated by Fiocruz, manufacturing generic medicines (including ARVs) for the federal public health system. Directly comparable as a government-owned pharma lab producing generics under public mandate, only with federal rather than São Paulo state remit.
• Bahiafarma: Bahia state pharmaceutical foundation producing medicines for the public system. Comparable state-owned pharma producer operating under a similar government-foundation model and generic-product mix in a different Brazilian state.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/furp-fundacao-para-o-remedio-popular

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fundacao Para o Remédio Popular